Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that ISX9 may activate the Wnt/β-catenin signaling pathway and holds potential as a therapeutic agent for treating alopecia.

This study found that combining ISX-9 with mesenchymal stem cells enhanced their ability to reduce inflammation and repair lung damage in an acute lung injury model compared to using the cells alone.

In this study, researchers developed a novel temperature-sensitive biopolymer-based drug delivery system that enhanced the transdermal delivery of ISX9, a neurogenesis inducer, resulting in more effective hair follicle regrowth and signal pathway activation in vivo compared to traditional topical application.

This study identified a small molecule that activates GLI1, suppressing neuroblastoma cell growth, which may aid in developing new treatments for high-risk neuroblastoma cases.

In this case study, a 10-month-old Doberman with generalized demodicosis recovered fully after treatment with a combination of systemic and topical therapies, including ivermectin, hydroxyzine, enrofloxacin, fluralaner, and specialized shampoos.